Doxorubicin-Conjugated Nanoparticles for Potential Use as Drug Delivery Systems
Doxorubicin (DOX) is one of the most widely used chemotherapy drugs in the treatment of both solid and liquid tumors in patients of all age groups. However, it is likely to produce several side effects that include doxorubicin cardiomyopathy. Nanoparticles (NPs) can offer targeted delivery and relea...
Saved in:
Main Authors: | Alua Imantay, Nariman Mashurov, Balnur A. Zhaisanbayeva, Ellina A. Mun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/15/2/133 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Streptomyces-derived nano-doxorubicin: Clinical status and patents granted
by: Kaur Prabhjot, et al.
Published: (2024-01-01) -
Recent advances in polymeric nanoparticles for the treatment of hepatic diseases
by: Feng Gao, et al.
Published: (2025-01-01) -
The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice
by: Amin Mehrabian, et al.
Published: (2023-04-01) -
Preparation of Ca-Mg Double-Doped Mesoporous Silica Nanoparticles and Their Drug-Loading and Drug-Releasing Properties
by: Qian Zhang, et al.
Published: (2025-01-01) -
Nanoparticle-in-Hydrogel Delivery System for the Sequential Release of Two Drugs
by: Demian van Straten, et al.
Published: (2025-01-01)